SpringWorks Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $61,549 | $49,301 | $59,733 | $21,006 |
Gross Profit | 55,995 | 45,960 | 57,280 | 19,075 |
EBITDA | -57,059 | -44,077 | -93,202 | |
EBIT | -57,937 | -44,921 | -93,931 | |
Net Income | -77,297 | -53,530 | -39,919 | -87,385 |
Net Change In Cash | 61,549 | 49,301 | 59,733 | 21,006 |
Free Cash Flow | -35,552 | -15,976 | -54,015 | -79,507 |
Cash | 69,751 | 84,456 | 79,898 | 118,031 |
Basic Shares | 74,403 | 74,264 | 74,121 | 73,768 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $191,589 | $5,447 | $6,147 | $35,000 |
Gross Profit | 179,039 | 5,025 | 6,147 | -490 |
EBITDA | -341,346 | -279,909 | -172,978 | |
EBIT | -343,013 | -280,674 | -173,468 | |
Net Income | -258,131 | -325,104 | -274,160 | -173,212 |
Net Change In Cash | 191,589 | 5,447 | 6,147 | 35,000 |
Free Cash Flow | -196,300 | -230,180 | -171,759 | -129,893 |
Cash | 69,751 | 176,053 | 67,490 | 103,961 |
Basic Shares | 74,403 | 63,123 | 53,290 | 48,497 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.04 |
2024-09-30 | -$0.72 |
2024-06-30 | -$0.54 |
2024-03-31 | -$1.18 |
